Below we include administration notes and a sample dosing protocol, with reference to clinical trial data involving this peptide
Goodman & Gilmans the pharmacological basis of therapeutics
Food and Drug Administration (FDA) European Medicines Agency (EMA) Therapeutic Goods Administration (TGA) Medicines and Healthcare products Regulatory Agency (MHRA) Due to the legal restrictions associated with SARMs intended for human consumption, these substances are typically available in powder or liquid formulations
Evaluation revealed B12 deficiency Treatment with B12 caused remittance of symptoms and resolution/improvement of abnormalities found on the imaging and electrodiagnostic studies
doi: 10.1158/1538-7445.AM2017-1279 108 Martnez-RizoAGonzlez-CordovaBPea-GeorgeC(CA-UAN-266) CA de IBNavarro-PartidaJGonzlez-CarrilloMet al
180 Vukovi-Cvetkovi, V., Plavec, D., Lovrenci-Huzjan, A., Galinovi, I., Seri, V